GenoLens logoGenoLens

Use Cases

Genomics research doesn't fit one mold —
neither do we

GenoLens adapts to the specific workflows, regulatory requirements, and output needs of different scientific communities.

🧬 Biotech & Pharmaceutical Industry

Accelerate from expression data to validated targets

Drug discovery is data-intensive. GenoLens eliminates the computational bottleneck between RNA-seq datasets and actionable biology — whether identifying targets, stratifying patient cohorts, or validating gene signatures for companion diagnostics.

🧬

Pharmaceutical R&D lab: scientist at multi-monitor workstation showing GenoLens volcano plot and pathway analysis. Drug target pipeline on whiteboard in background. Professional blue-tinted laboratory lighting.

The challenges GenoLens solves

⏱️
Bioinformatics bottleneck

Weeks of pipeline maintenance delays wet-lab results. GenoLens removes the computational barrier entirely.

🔄
Reproducibility concerns

Regulatory submissions demand traceable analyses. GenoLens records every parameter, version, and step.

🧩
Multi-study integration

Comparing across GEO datasets, internal studies, and clinical cohorts requires normalisation expertise — GenoLens handles it.

📋
Reporting overhead

Generating reports for stakeholders, IP teams, and regulators consumes precious research time.

Typical Workflow

Step-by-step pipeline

1
Disease vs. healthy cohort upload
Upload bulk RNA-seq count matrices. Automatic sample QC and outlier detection included.
2
Multi-contrast differential expression
Run DEG across severity grades or treatment arms. Identify disease-specific gene signatures simultaneously.
3
Target prioritisation by AI
AI cross-references DEGs against druggability databases and generates ranked target hypotheses with literature support.
4
Signature export for validation
Export gene signatures in formats compatible with qPCR primer design tools, IHC panels, or flow cytometry gatings.
🖥️

GenoLens biotech workflow dashboard: analysis pipeline visualization specific to Biotech & Pharma sector. Dark theme, cyan accents.

10×
Faster target identification vs. in-house pipeline
100%
Reproducible, auditable analyses for regulatory submissions
3+
Biotech teams reduced their bioinformatics headcount needs
<2h
From raw counts to AI-interpreted results

GenoLens allowed our discovery team to test 18 disease gene signatures in parallel over a single weekend. That experiment would have taken three weeks through our previous computational biology queue.

— Head of Translational Genomics, European Biotech (name withheld per NDA)

Start Today

Explore how GenoLens fits your research

Book a 30-minute demo tailored to your sector. Our scientific team will walk through a real analysis with your data if you wish.